跳至主要内容
临床试验/NCT03687723
NCT03687723已完成不适用

Observational Study of the Clinical Use of the Organ Care System (OCS™) in Heart Transplantation

Hannover Medical School1 个研究点 分布在 1 个国家目标入组 93 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
93
试验地点
1
主要终点
Patient Survival

研究概览

简要总结

Single-arm, prospective, multi-center observational study of the clinical use of the ex-vivo perfusion of the heart with the Organ Care System (OCS™)

详细描述

This is an observational study at two centers that will enroll minimum of 60 heart transplant recipients transplanted with donor heart preserved using the OCS™ Heart System. All consented subjects who receive OCS™-preserved heart transplants will be approached for participation. The study will evaluate short and long-term effectiveness of the OCS™ Heart System for heart transplantation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All recipients of heart transplantation with Use of the OCS™ Heart

排除标准

  • Donor Hearts
  • Presence of coronary heart diseases
  • acute myocardial infarction
  • Presence of heart valve disease (Stenosis or Insufficiency > first degree)
  • Presence of left ventricular hypertrophy (septum and posterior wall thickness >1.7 cm)
  • State of shock of donor (MAP <60 mmHg, CVP >15, PCWP >15 mmHg) with use of Dobutamine >10 ug/kg/min and/or Norepinephrine > 0.5 ug/kg/min or Epinephrine > 0.2 ug/kg/min
  • irreversible persistant pulmonary hypertrophy, defined as transpulmonary gradient >15 mmHg of the recipient

结局指标

主要结局

Patient Survival

时间窗: 12 months

12-month patient survival post heart transplant Primary Effectiveness Endpoint

次要结局

  • Patient and Graft Survival(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验